SCHEMBL19632907

SCHEMBL19632907

CNCCC(=O)CNC(=O)CNC(=O)CNC(=O)CSC(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 2/20 0.47
KMT2A Q03164 5/20 0.46
MAPT P10636 4/20 0.46
ALDH1A1 P00352 3/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.40
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
TAAR1 Q96RJ0 1/20 0.34
GAA P10253 2/20 0.34
CARM1 Q86X55 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16135523 0.86 KMT2A (0.50) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL16088020 0.85 GPR139 (0.47) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL16088015 0.84 KMT2A (0.45) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL8387484 0.83 GPR139 (0.55) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL19034783 0.81 GPR139 (0.54) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL14417102 0.81 GPR139 (0.52) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL1055212 0.81 GPR139 (0.52) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL16088025 0.80 KMT2A (0.44) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL10309087 0.80 KMT2A (0.51) GPR139KMT2AMAPTALDH1A1HTT
SCHEMBL16135531 0.80 GPR139 (0.47) GPR139KMT2AMAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170333579-A1 COMPOSITIONS AND ASSOCIATED METHODS FOR RADIOISOTOPE-BINDING MICROPARTICLES WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333579-A1 COMPOSITIONS AND ASSOCIATED METHODS FOR RADIOISOTOPE-BINDING MICROPARTICLES CD47, CD68, MPI GPR139 2678/4885KMT2A 4620/4885MAPT 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.